Ozanezumab Biosimilar - Anti-Nogo Antibody - Low endotoxin, Azide free (A323644)

Ozanezumab Biosimilar - Anti-Nogo Antibody - Low endotoxin, Azide free

Recombinant humanized monoclonal antibody to Nogo.

ELISA, FACS, Functional Assay, In Vivo

Human

Humanized

Monoclonal

IgG1

kappa

Unconjugated

Protein A affinity chromatography.

Reconstitution dependent.

> 90% (by SDS-PAGE and SEC-HPLC).

Lyophilized

Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!

Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.

Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.

1110020G17Rik, AA407876, AA409940, AA960376, ASY, C130026I10Rik, Foocen, Glut4 vesicle 20 kDa protein, Human NogoA, Kiaa0886, KIAA4153, MGC116054, MGC139261, mKIAA0886, mKIAA4153, My043 protein, Nbla00271, Nbla10545, Neurite growth inhibitor 220, Neurite Growth Inhibitor 220, included, Neurite outgrowth inhibitor, Neuroendocrine-specific protein, Neuroendocrine-specific protein C homolog, NI-250, NI220/250, Nogo A, Nogo B, Nogo C, Nogo protein, NOGOC, NSP, NSP-CL, rat N, Reticulon 4, Reticulon 5, Reticulon-4, Reticulon-5, RTN X, RTN-x, Rtn4, Rtn4 reticulon 4, RTN4-A, RTN4-B1, RTN4-B2, RTN4-C, RTN4_HUMAN, Vp20